| Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease D Blum, S Torch, N Lambeng, MF Nissou, AL Benabid, R Sadoul, ... Progress in neurobiology 65 (2), 135-172, 2001 | 1641 | 2001 |
| NLRP3 inflammasome activation drives tau pathology C Ising, C Venegas, S Zhang, H Scheiblich, SV Schmidt, A Vieira-Saecker, ... Nature 575 (7784), 669-673, 2019 | 1077 | 2019 |
| 3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease E Brouillet, C Jacquard, N Bizat, D Blum Journal of neurochemistry 95 (6), 1521-1540, 2005 | 413 | 2005 |
| Biochemistry of Tau in Alzheimer’s disease and related neurological disorders N Sergeant, A Bretteville, M Hamdane, ML Caillet-Boudin, P Grognet, ... Expert review of proteomics 5 (2), 207-224, 2008 | 351 | 2008 |
| Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies? C Laurent, L Buée, D Blum Biomedical journal 41 (1), 21-33, 2018 | 347 | 2018 |
| Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment H Le Freche, J Brouillette, FJ Fernandez-Gomez, P Patin, R Caillierez, ... The Journal of the American Society of Anesthesiologists 116 (4), 779-787, 2012 | 289 | 2012 |
| Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy C Laurent, G Dorothée, S Hunot, E Martin, Y Monnet, M Duchamp, ... Brain 140 (1), 184-200, 2017 | 245 | 2017 |
| Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology A Sierksma, A Lu, R Mancuso, N Fattorelli, N Thrupp, E Salta, J Zoco, ... EMBO molecular medicine 12 (3), e10606, 2020 | 239 | 2020 |
| Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach L Troquier, R Caillierez, S Burnouf, F J Fernandez-Gomez, ME Grosjean, ... Current Alzheimer Research 9 (4), 397-405, 2012 | 237 | 2012 |
| Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1–42 oligomers are revealed in vivo by using a novel animal model J Brouillette, R Caillierez, N Zommer, C Alves-Pires, I Benilova, D Blum, ... Journal of Neuroscience 32 (23), 7852-7861, 2012 | 219 | 2012 |
| Tau deletion promotes brain insulin resistance E Marciniak, A Leboucher, E Caron, T Ahmed, A Tailleux, J Dumont, ... Journal of Experimental Medicine 214 (8), 2257-2269, 2017 | 218 | 2017 |
| Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology C Laurent, S Eddarkaoui, M Derisbourg, A Leboucher, D Demeyer, ... Neurobiology of aging 35 (9), 2079-2090, 2014 | 215 | 2014 |
| Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology K Belarbi, S Burnouf, FJ Fernandez-Gomez, C Laurent, S Lestavel, ... Neurobiology of disease 43 (2), 486-494, 2011 | 205 | 2011 |
| Atypical, non-standard functions of the microtubule associated Tau protein I Sotiropoulos, MC Galas, JM Silva, E Skoulakis, S Wegmann, MB Maina, ... Acta neuropathologica communications 5, 1-11, 2017 | 203 | 2017 |
| Clinical potential of minocycline for neurodegenerative disorders D Blum, A Chtarto, L Tenenbaum, J Brotchi, M Levivier Neurobiology of disease 17 (3), 359-366, 2004 | 200 | 2004 |
| A2A adenosine receptor deletion is protective in a mouse model of Tauopathy C Laurent, S Burnouf, B Ferry, VL Batalha, JE Coelho, Y Baqi, E Malik, ... Molecular psychiatry 21 (1), 97-107, 2016 | 185 | 2016 |
| Extracellular toxicity of 6-hydroxydopamine on PC12 cells D Blum, S Torch, MF Nissou, AL Benabid, JM Verna Neuroscience letters 283 (3), 193-196, 2000 | 178 | 2000 |
| Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors M Temido-Ferreira, DG Ferreira, VL Batalha, I Marques-Morgado, ... Molecular psychiatry 25 (8), 1876-1900, 2020 | 176 | 2020 |
| Role of the Tau N-terminal region in microtubule stabilization revealed by newendogenous truncated forms M Derisbourg, C Leghay, G Chiappetta, FJ Fernandez-Gomez, C Laurent, ... Scientific reports 5 (1), 9659, 2015 | 168 | 2015 |
| Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics D Blum, R Hourez, MC Galas, P Popoli, SN Schiffmann The Lancet Neurology 2 (6), 366-374, 2003 | 165 | 2003 |
Luc BueeUniversité de LilleDirección de correo verificada de univ-lille.fr